Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Junichi Asano, Hiroyuki Sato, Shin Watanabe, Akihiro Hirakawa |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026)
by: Pavla Krotka, et al.
Published: (2026)
An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
by: Tianyu Zhan, et al.
Published: (2025)
by: Tianyu Zhan, et al.
Published: (2025)
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome
by: Xinxin Sun, et al.
Published: (2024)
by: Xinxin Sun, et al.
Published: (2024)
BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
by: Ryo Kitabayashi, et al.
Published: (2025)
by: Ryo Kitabayashi, et al.
Published: (2025)
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
by: Ruoyuan Qian, et al.
Published: (2025)
by: Ruoyuan Qian, et al.
Published: (2025)
A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
by: Antonio Olivas‐Martinez, et al.
Published: (2026)
by: Antonio Olivas‐Martinez, et al.
Published: (2026)
Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)
by: Yunyi Liu, et al.
Published: (2026)
A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods
by: Lori P. Selby, et al.
Published: (2025)
by: Lori P. Selby, et al.
Published: (2025)
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
by: Zifei Han, et al.
Published: (2025)
by: Zifei Han, et al.
Published: (2025)
Adaptive Seamless Phase II / III Randomization Test Considering Treatment Group Selection Based on Short–Term Binary Outcomes
by: Funato Sato, et al.
Published: (2026)
by: Funato Sato, et al.
Published: (2026)
Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)
by: Daniel E. Schwartz, et al.
Published: (2026)
Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)
by: Jingyan Fu, et al.
Published: (2025)
Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)
by: Antonio D'Alessandro, et al.
Published: (2026)
Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example
by: Mikail Nourredine, et al.
Published: (2025)
by: Mikail Nourredine, et al.
Published: (2025)
An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
by: Erik W. van Zwet, et al.
Published: (2026)
by: Erik W. van Zwet, et al.
Published: (2026)
On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach
by: Marco Ratta, et al.
Published: (2026)
by: Marco Ratta, et al.
Published: (2026)
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome
by: Dan Liu, et al.
Published: (2024)
by: Dan Liu, et al.
Published: (2024)
Statistical Inference for Association Studies in the Presence of Binary Outcome Misclassification
by: Kimberly A. Hochstedler Webb, et al.
Published: (2025)
by: Kimberly A. Hochstedler Webb, et al.
Published: (2025)
Bayesian Ordered Lattice Design for Phase I Clinical Trials
by: Gi‐Ming Wang, et al.
Published: (2026)
by: Gi‐Ming Wang, et al.
Published: (2026)
Bayesian Estimation of Hierarchical Linear Models From Incomplete Data: Cluster‐Level Interaction Effects and Small Sample Sizes
by: Dongho Shin, et al.
Published: (2025)
by: Dongho Shin, et al.
Published: (2025)
Bayesian Pliable Lasso With Horseshoe Prior for Interaction Effects in GLMs With Missing Responses
by: The Tien Mai
Published: (2026)
by: The Tien Mai
Published: (2026)
Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
by: Tianyu Zhan, et al.
Published: (2026)
by: Tianyu Zhan, et al.
Published: (2026)
Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
by: M. C. Donohue, et al.
Published: (2025)
by: M. C. Donohue, et al.
Published: (2025)
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)
by: Florian Klinglmüller, et al.
Published: (2025)
Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)
by: Ethan Ashby, et al.
Published: (2025)
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)
by: Fei Gao, et al.
Published: (2025)
Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
by: Kendra Davis‐Plourde, et al.
Published: (2025)
by: Kendra Davis‐Plourde, et al.
Published: (2025)
A Bayesian Prevalence‐Incidence Mixture Model for Screening Outcomes With Misclassification
by: Thomas Klausch, et al.
Published: (2026)
by: Thomas Klausch, et al.
Published: (2026)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Moka Komaki, et al.
Published: (2026)
by: Moka Komaki, et al.
Published: (2026)
Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
by: Hyejung Jung, et al.
Published: (2026)
by: Hyejung Jung, et al.
Published: (2026)
Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
by: Guoqiao Wang, et al.
Published: (2025)
by: Guoqiao Wang, et al.
Published: (2025)
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
by: Juhee Lee, et al.
Published: (2024)
by: Juhee Lee, et al.
Published: (2024)
Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
by: Analissa Avila, et al.
Published: (2025)
by: Analissa Avila, et al.
Published: (2025)
Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
by: Jiaqi Tong, et al.
Published: (2025)
by: Jiaqi Tong, et al.
Published: (2025)
BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes
by: Cheng‐Han Yang, et al.
Published: (2026)
by: Cheng‐Han Yang, et al.
Published: (2026)
A Fully‐Integrated Bayesian Approach for the Imputation and Analysis of Derived Outcome Variables With Missingness
by: Harlan Campbell, et al.
Published: (2026)
by: Harlan Campbell, et al.
Published: (2026)
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data
by: Yunju Im, et al.
Published: (2025)
by: Yunju Im, et al.
Published: (2025)
Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)
by: Xiaotian Chen, et al.
Published: (2025)
A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
by: Yichen Yan, et al.
Published: (2025)
by: Yichen Yan, et al.
Published: (2025)
Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
by: Wenli Liu, et al.
Published: (2025)
by: Wenli Liu, et al.
Published: (2025)
Similar Items
-
On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026) -
An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
by: Tianyu Zhan, et al.
Published: (2025) -
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome
by: Xinxin Sun, et al.
Published: (2024) -
BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
by: Ryo Kitabayashi, et al.
Published: (2025) -
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
by: Ruoyuan Qian, et al.
Published: (2025)